Related Articles
Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment
EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling
High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin
Delta‑like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma
Potential biomarkers for the therapeutic efficacy of sorafenib, sunitinib and everolimus